ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in New York, NY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Triple Negative Breast Cancer
Colorectal Cancer

Lung Cancer trials near New York, NY, USA:

Virtual Personalized Exercise Program for Lung Cancer Patients

This is a prospective study providing lung cancer subjects at R.J. Zuckerberg Cancer Center with a customized exercise pro ...

Enrolling
Lung Cancer
Behavioral: Salaso Virtual Exercise Program
Northwell Health
Northwell Health

New Hyde Park, New York, United States

of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical str...

Enrolling
Lung Cancer Stage I
Lung Cancer
Device: CivaSheet

Phase 2

CivaTech Oncology

New York, New York, United States

with a type of radiation therapy called stereotactic body radiation (SBRT) is a more effective treatment for early-stage non-small cell lung ...

Active, not recruiting
Non-small Cell Lung Cancer Stage II
Non-small Cell Lung Cancer Stage IIIA
Radiation: Stereotactic Body Radiation Therapy
Drug: Durvalumab

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

New York, New York, United States and 8 other locations

This is a phase I clinical trial to determine the maximum tolerated dose (MTD) of KK-LC-1 TCR-T cells for the treatment of metastatic cancers...

Enrolling
Breast Cancer
Gastric Cancer
Drug: Aldesleukin
Biological: KK-LC-1 TCR-T cells

Phase 1

Christian Hinrichs

New Brunswick, New Jersey, United States and 1 other location

chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...

Enrolling
Metastatic Non-small Cell Lung Cancer
Drug: Osimertinib
Drug: Carboplatin

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

New York, New York, United States and 17 other locations

a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...

Enrolling
Metastatic Non Small Cell Lung Cancer
Biological: LN-145

Phase 2

Iovance Biotherapeutics

New York, New York, United States and 63 other locations

Study of MGY825 single agent in adult patients with advanced non-small cell lung cancer....

Enrolling
Non-small Cell Lung Cancer
Drug: MGY825

Phase 1

Novartis
Novartis

New York, New York, United States and 15 other locations

This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: DS-1062a

Phase 2

Daiichi Sankyo
Daiichi Sankyo

New York, New York, United States and 83 other locations

with advanced/metastatic or relapsed/progressive small cell lung cancer (SCLC) and non small cell lung cancer (NS...

Enrolling
Advanced Lung Cancer
Biological: BNT327
Biological: BNT324

Phase 1, Phase 2

BioNTech
BioNTech

Hackensack, New Jersey, United States and 5 other locations

with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Docetaxel
Drug: DS-1062a

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Bronx, New York, United States and 209 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems